🔎 What does it take to stay ahead in today’s dynamic pharma landscape?

At the BIO2025 roundtable, Peter Belden, President of Tjoapack US, shares how we’re addressing rising demand for injectable and temperature-sensitive therapies—through investments in GMP-qualified coldchain, automated sterile packaging, and diversified delivery systems.

🔗 Read Peter’s insights on building a more resilient, flexible pharmaceutical supply chain.

‍

‍